- The last few years have seen a marked increase in the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) used for managing type 2 diabetes and as a way to lose weight.
- This rapid increase in users of GLP-1 drugs has caused worldwide shortages of these medications for people with type 2 diabetes who need them.
- A new study…
Read the full article here